StockWatch
·
Pharmaceuticals
Shareholding18 Jun 2026, 06:20 pm

Promoter Sells 34.56% Stake in Colinz Labs for ₹4.35 Cr

AI Summary

Colinz Laboratories Limited has announced a significant promoter share sale. Ms. Vijaya Mani, a promoter, has executed a Share Purchase Agreement (SPA) to sell 8,70,500 equity shares, representing 34.56% of the company's total voting share capital, to Annjana Dugar, Likhitta Dugar, and Antraiksh Dugar. The transaction is valued at ₹50 per equity share, totaling approximately ₹4.35 crore. The sale is subject to certain conditions, and upon completion, the Acquirers will gain control and management rights of the company. As per SEBI regulations, the Acquirers are required to make an Open Offer to the public shareholders.

Key Highlights

  • Promoter sells 34.56% stake in Colinz Laboratories.
  • Transaction value is ₹50 per share, totaling ₹4.35 crore.
  • Acquirers will gain control and management rights.
  • Open Offer to public shareholders will be made.
  • Sale is subject to fulfillment of certain conditions.